FDA approves daily HIV pill from Gilead designed to simplify treatment for some patients - CNBC

As reported by CNBC

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Market Samachar is a news aggregator. This article was originally published by CNBC. Tap the button above to read the full story on their site.

More from Market Samachar